Bearberry in the treatment of acute uncomplicated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial
暂无分享,去创建一个
P. Hegyi | P. Nyirády | K. Naber | D. Csupor | N. Gede | N. Vörhendi | S. Váncsa | B. Tóth | G. Zhanel | R. Länger | A. Jávorházy | B. Csupor‐Löffler | Péter Birinyi
[1] L. Peixe,et al. Escherichia coli resistant to fosfomycin from urinary tract infections: Detection of the fosA3 gene in Spain. , 2020, Journal of global antimicrobial resistance.
[2] K. Naber,et al. Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II , 2019, World Journal of Urology.
[3] G. Lewith,et al. Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] A. Peleg,et al. Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems. , 2019, Australian prescriber.
[5] T. Friede,et al. Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) – a double-blind, randomized, controlled comparative effectiveness trial , 2018, BMC Complementary and Alternative Medicine.
[6] L. Leibovici,et al. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial , 2018, JAMA.
[7] S. Schmidt,et al. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention , 2018, Urologia Internationalis.
[8] K. Naber,et al. The role of the Acute Cystitis Symptom Score questionnaire for research and antimicrobial stewardship. Validation of the Hungarian version , 2017, Central European journal of urology.
[9] S. Schmidt,et al. [Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline]. , 2017, Der Urologe. Ausg. A.
[10] K. Naber,et al. Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten , 2017, Der Urologe.
[11] S. Harbarth,et al. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. , 2015, The Journal of antimicrobial chemotherapy.
[12] K. Naber,et al. New Self-Reporting Questionnaire to Assess Urinary Tract Infections and Differential Diagnosis: Acute Cystitis Symptom Score , 2014, Urologia Internationalis.
[13] G. Keating. Fosfomycin Trometamol: A Review of Its Use as a Single-Dose Oral Treatment for Patients with Acute Lower Urinary Tract Infections and Pregnant Women with Asymptomatic Bacteriuria , 2013, Drugs.
[14] D. Rennie,et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.
[15] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] D. Coplen. Executive Summary: International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases , 2011 .
[17] J. Campos,et al. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. , 2010, The Journal of antimicrobial chemotherapy.
[18] Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections , 2010 .
[19] K. Naber,et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. , 2008, European urology.
[20] J. Mulder,et al. Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women , 1993, Pharmacy World and Science.
[21] G. Stein. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. , 1999, Clinical therapeutics.
[22] G. Duckworth,et al. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. , 1999, International journal of antimicrobial agents.
[23] S. Moskalenko. Preliminary screening of far-eastern ethnomedicinal plants for antibacterial activity. , 1986, Journal of ethnopharmacology.